SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Piffer OT - And Other Assorted Nuts -- Ignore unavailable to you. Want to Upgrade?

To: Jorj X Mckie who wrote (9523)12/13/1999 4:50:00 PM
From: John Pitera  Read Replies (3) | Respond to of 63513
 
bought Fro which converted into GBLX and the basis in GBLX was 22.00

FRO closed at 35 or 34 one day on a late day sell off and GBLX, that was a day when GBLX could have been bought for 17 and change.

since GBLX and Qwst have been on the Master Buy List for Mike and I since Early Q2, we were able to stick to our guns and buy on weakness.

You shall have courage to buy during the dark days that shall occur at some point in the next 2 or 3 Q's. SInce you are now involved in crafting the Master Buy List -g-

John



To: Jorj X Mckie who wrote (9523)12/13/1999 4:53:00 PM
From: Ms. X  Read Replies (2) | Respond to of 63513
 
ARTC just announced an FDA approval of a way to shrink tissues either during or after back surgery. This would reduce swelling and I'm hoping scar tissue which is the primary cause of problems after surgery.

The stock rose significantly on the news. Yesterday it had reversed up after a long tail down.

I would watch this one. Anything that helps reduce pain from back surgeries is a hot item.

Believe me, I know.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News